Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引：0
|
作者：
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构：
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-143
引用
下载
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [41] Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients:: a combined analysis of eight multicenter trials
    Mann, J.
    Kessler, M.
    Villa, G.
    Martinez-Castelao, A.
    Feldt-Rasmussen, B.
    Cruz, J.
    Hoerl, W. H.
    Mattin, C.
    Praml, C.
    Wilkie, M.
    CLINICAL NEPHROLOGY, 2007, 67 (03) : 140 - 148
  • [42] CLINICAL OUTCOMES OF AML PATIENTS TREATED WITH AZACITIDINE IN PORTUGAL: A RETROSPECTIVE MULTICENTER STUDY
    Almeida, A. M.
    Ferreira, A. R.
    Costa, M. J.
    Conde, I.
    Bogalho, I.
    Alnajjar, K.
    Alpoim, M.
    Esteves, S.
    Bras, G.
    Cortesao, E.
    Pinto, R.
    LEUKEMIA RESEARCH, 2015, 39 : S100 - S100
  • [43] CLINICAL OUTCOMES OF AML PATIENTS TREATED WITH AZACITIDINE IN PORTUGAL: A RETROSPECTIVE MULTICENTER STUDY
    Almeida, A.
    Ferreira, A. R.
    Costa, M. J.
    Sofia, S.
    Alnajjar, K.
    Isabel, B.
    Pierdomenico, F.
    Mafalda, A.
    Braz, G.
    Cortesao, E.
    Pinto, R.
    HAEMATOLOGICA, 2015, 100 : 385 - 385
  • [44] Clinical Characteristics and Prognosis in South-American Patients with Myelodysplastic Syndrome: A Multicenter Study
    Belli, Carolina
    Pinheiro, Ronald Feitosa
    Gabriela Flores, Maria
    Magalhaes, Silvia M. M.
    Kornblihtt, Laura
    Enrico, Alicia
    Cordeiro, Juliana
    Lisa Basquiera, Ana
    de Andrade Silva, Marcela Cavalcante
    da Silva Tanizawa, Roberta
    Pintos, Noemi
    Alfonso, Graciela
    Arbelbide, Jorge
    Sakamoto, Francisco
    Watman, Nora
    Valladares Ticona, Ximena
    Larripa, Irene B.
    Undurraga, Soledad S.
    Velloso, Elvira R. P.
    BLOOD, 2014, 124 (21)
  • [45] Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis
    Karadag, Fatma Keklik
    Yenerel, Mustafa Nuri
    Yilmaz, Mehmet
    Uskudar, Hava
    Ozkocaman, Vildan
    Tuglular, Tulin Firatli
    Erdem, Fuat
    Unal, Ali
    Ayyildiz, Orhan
    Ozet, Gulsum
    Comert, Melda
    Kaya, Emin
    Ayer, Mesut
    Salim, Ozan
    Guvenc, Birol
    Ozdogu, Hakan
    Mehtap, Ozgur
    Sonmez, Mehmet
    Guler, Nil
    Hacioglu, Sibel
    Aydogdu, Ismet
    Bektas, Ozlen
    Toprak, Selami Kocak
    Kaynar, Lale
    Yagci, Munci
    Aksu, Salih
    Tombak, Anil
    Karakus, Volkan
    Yavasoglu, Irfan
    Onec, Birgul
    Ozcan, Mehmet Ali
    Undar, Levent
    Ali, Ridvan
    Ilhan, Osman
    Saydam, Guray
    Sahin, Fahri
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (03): : 279 - 285
  • [46] ANEMIA AND DARBEPOETIN ALFA ADMINISTRATION IN PATIENTS TREATED WITH CHOP+/-R CHEMOTHERAPY: RESULTS FROM AN OBSERVATIONAL STUDY OF PATIENTS WITH NON-HODGKIN LYMPHOMA
    Haioun, C.
    Lugtenburg, P.
    Pettengell, R.
    Johnsen, H. E.
    Duehrsen, U.
    Rossi, F. G.
    Verhoef, G.
    Schwenkglenks, M.
    Pujol, B.
    Salar, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 387 - 387
  • [47] Comparative Efficacy and Safety Study of Darbepoetin Alfa versus Epoetin Alfa in Management of Anemia Associated with ESRD in Egyptian Hemodialysis Patients
    El-Ashmawy, Nahla E.
    Khedr, Eman G.
    Kotb, Nahla S.
    Salem, Fathi
    Ibrahim, Amera O.
    CURRENT DRUG SAFETY, 2022, 17 (03) : 250 - 258
  • [48] Darbepoetin alfa maintains hemoglobin levels in patients with myelodysplastic syndromes (MDS) after therapeutic interchange from epoetin alfa: Results of a retrospective chart review.
    Patton, J
    Mun, Y
    Wallace, J
    BLOOD, 2004, 104 (11) : 261B - 261B
  • [49] Weekly epoetin alfa (QW) provides similar hematologic outcomes to front-loading (FL) darbepoetin alfa regimens and better outcomes compared to darbepoetin alfa (Q2W) in patients with chemotherapy-related anemia.
    Duh, MS
    Lefebvre, P
    Dector, AJ
    Watson, SH
    McKenzie, SR
    Piech, CT
    BLOOD, 2003, 102 (11) : 511B - 512B
  • [50] Comparing the cost-effectiveness of front loaded darbepoetin alfa with epoetin alfa for anemia management in chemotherapy-treated cancer patients in United States
    Glaspy, J
    Tchekmedyian, N
    Gupta, S
    VALUE IN HEALTH, 2002, 5 (06) : 538 - 538
12345